8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine

C96H88F15N33O4 — CID 159766387

IUPAC8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine
SMILESCc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCN(C)CC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCOCC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCCC3)n[nH]1
InChIInChI=1S/C23H23F3N8.C22H20F3N7O.C18H17F3N6O.C17H15F3N6O.C16H13F3N6O/c1-14-27-22(32-31-14)30-21-16-7-5-9-18(34-12-10-33(2)11-13-34)19(16)28-20(29-21)15-6-3-4-8-17(15)23(24,25)26;1-13-26-21(31-30-13)29-20-15-6-4-8-17(32-9-11-33-12-10-32)18(15)27-19(28-20)14-5-2-3-7-16(14)22(23,24)25;1-10-22-17(27-26-10)25-16-14-13(8-4-5-9-28-14)23-15(24-16)11-6-2-3-7-12(11)18(19,20)21;1-9-21-16(26-25-9)24-15-13-12(7-4-8-27-13)22-14(23-15)10-5-2-3-6-11(10)17(18,19)20;1-8-20-15(25-24-8)23-14-12-11(6-7-26-12)21-13(22-14)9-4-2-3-5-10(9)16(17,18)19/h3-9H,10-13H2,1-2H3,(H2,27,28,29,30,31,32);2-8H,9-12H2,1H3,(H2,26,27,28,29,30,31);2-3,6-7H,4-5,8-9H2,1H3,(H2,22,23,24,25,26,27);2-3,5-6H,4,7-8H2,1H3,(H2,21,22,23,24,25,26);2-5H,6-7H2,1H3,(H2,20,21,22,23,24,25)
InChIKeyNFOAHWYPDNDLMK-UHFFFAOYSA-N
MW2052.96 g/mol
LogP19.53
Rot. Bonds17

About 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine

8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine (PubChem CID 159766387) has the molecular formula C96H88F15N33O4 and a molecular weight of 2052.96 g/mol. Its IUPAC name is 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine.

Molecular Properties

Compound Name8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine
PubChem CID159766387
Molecular FormulaC96H88F15N33O4
Molecular Weight2052.96 g/mol
Exact Mass2051.75
IUPAC Name8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine
SMILESCc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCN(C)CC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCOCC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCCC3)n[nH]1
InChIInChI=1S/C23H23F3N8.C22H20F3N7O.C18H17F3N6O.C17H15F3N6O.C16H13F3N6O/c1-14-27-22(32-31-14)30-21-16-7-5-9-18(34-12-10-33(2)11-13-34)19(16)28-20(29-21)15-6-3-4-8-17(15)23(24,25)26;1-13-26-21(31-30-13)29-20-15-6-4-8-17(32-9-11-33-12-10-32)18(15)27-19(28-20)14-5-2-3-7-16(14)22(23,24)25;1-10-22-17(27-26-10)25-16-14-13(8-4-5-9-28-14)23-15(24-16)11-6-2-3-7-12(11)18(19,20)21;1-9-21-16(26-25-9)24-15-13-12(7-4-8-27-13)22-14(23-15)10-5-2-3-6-11(10)17(18,19)20;1-8-20-15(25-24-8)23-14-12-11(6-7-26-12)21-13(22-14)9-4-2-3-5-10(9)16(17,18)19/h3-9H,10-13H2,1-2H3,(H2,27,28,29,30,31,32);2-8H,9-12H2,1H3,(H2,26,27,28,29,30,31);2-3,6-7H,4-5,8-9H2,1H3,(H2,22,23,24,25,26,27);2-3,5-6H,4,7-8H2,1H3,(H2,21,22,23,24,25,26);2-5H,6-7H2,1H3,(H2,20,21,22,23,24,25)
InChIKeyNFOAHWYPDNDLMK-UHFFFAOYSA-N
XLogP19.53
TPSA443.54 Ų
H-Bond Donors10
H-Bond Acceptors32
Rotatable Bonds17
Heavy Atoms148
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002052.96
LogP ≤ 519.53
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1032

Analyze 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(5,7-difluoro-1H-indazol-3-yl)-6-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-8-(4-methylpiperazin-1-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(7-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-amine;N-(1H-indazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
CID 157116096
2-(2-chlorophenyl)-N-(5-fluoro-1H-indazol-3-yl)pteridin-4-amine;N-(5,7-difluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]pteridin-4-amine;N-(5-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-fluoro-1H-indazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine
CID 159519438
N-[6-(2-aminoethoxy)-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazin-3-yl]-1H-indazol-3-amine;6-N-(2-aminoethyl)-3-N-(1H-indazol-3-yl)-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazine-3,6-diamine;6-N-[2-(dimethylamino)ethyl]-3-N-(1H-indazol-3-yl)-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazine-3,6-diamine;N-[6-(2-piperidin-1-ylethoxy)-5-[2-(trifluoromethyl)phenyl]pyridazin-3-yl]-1H-indazol-3-amine
CID 160791307
1-N-ethyl-6-N-(2H-pyrazolo[3,4-b]pyridin-3-yl)isoquinoline-1,6-diamine;8-N-ethyl-3-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)quinoline-3,8-diamine;1-indol-1-yl-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;1-(4-methylphenoxy)-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine;1-morpholin-4-yl-N-(1H-pyrazolo[4,3-b]pyridin-3-yl)isoquinolin-6-amine
CID 158657898

Frequently Asked Questions

What is the IUPAC name of 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine?
The IUPAC name of 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine (CID 159766387) is 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine.
What is the SMILES notation for 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine?
The canonical SMILES for 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine is Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCN(C)CC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c(N4CCOCC4)cccc23)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCC3)n[nH]1.Cc1nc(Nc2nc(-c3ccccc3C(F)(F)F)nc3c2OCCCC3)n[nH]1.
What is the InChIKey of 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine?
The InChIKey is NFOAHWYPDNDLMK-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23F3N8.C22H20F3N7O.C18H17F3N6O.C17H15F3N6O.C16H13F3N6O/c1-14-27-22(32-31-14)30-21-16-7-5-9-18(34-12-10-33(2)11-13-34)19(16)28-20(29-21)15-6-3-4-8-17(15)23(24,25)26;1-13-26-21(31-30-13)29-20-15-6-4-8-17(32-9-11-33-12-10-32)18(15)27-19(28-20)14-5-2-3-7-16(14)22(23,24)25;1-10-22-17(27-26-10)25-16-14-13(8-4-5-9-28-14)23-15(24-16)11-6-2-3-7-12(11)18(19,20)21;1-9-21-16(26-25-9)24-15-13-12(7-4-8-27-13)22-14(23-15)10-5-2-3-6-11(10)17(18,19)20;1-8-20-15(25-24-8)23-14-12-11(6-7-26-12)21-13(22-14)9-4-2-3-5-10(9)16(17,18)19/h3-9H,10-13H2,1-2H3,(H2,27,28,29,30,31,32);2-8H,9-12H2,1H3,(H2,26,27,28,29,30,31);2-3,6-7H,4-5,8-9H2,1H3,(H2,22,23,24,25,26,27);2-3,5-6H,4,7-8H2,1H3,(H2,21,22,23,24,25,26);2-5H,6-7H2,1H3,(H2,20,21,22,23,24,25).
What are the key properties of 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine?
8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine has a molecular weight of 2052.96 g/mol, XLogP of 19.53, 17 rotatable bonds, 10 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 8-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-8-morpholin-4-yl-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7-dihydrofuro[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-7,8-dihydro-6H-pyrano[3,2-d]pyrimidin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]-6,7,8,9-tetrahydrooxepino[3,2-d]pyrimidin-4-amine is sourced from PubChem (CID 159766387), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).